Erez Podoly

774 total citations
12 papers, 657 citations indexed

About

Erez Podoly is a scholar working on Pharmacology, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Erez Podoly has authored 12 papers receiving a total of 657 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 5 papers in Molecular Biology and 5 papers in Computational Theory and Mathematics. Recurrent topics in Erez Podoly's work include Cholinesterase and Neurodegenerative Diseases (9 papers), Computational Drug Discovery Methods (5 papers) and Alzheimer's disease research and treatments (4 papers). Erez Podoly is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (9 papers), Computational Drug Discovery Methods (5 papers) and Alzheimer's disease research and treatments (4 papers). Erez Podoly collaborates with scholars based in Israel, United States and Bulgaria. Erez Podoly's co-authors include Hermona Soreq, Oded Livnah, Ella H. Sklan, Sophia Diamant, Assaf Friedler, Hagai Ligumsky, Estelle R. Bennett, H. S. Wilgus, Geula Hanin and Eran Meshorer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Molecular Biology.

In The Last Decade

Erez Podoly

12 papers receiving 651 citations

Peers

Erez Podoly
Hyun‐Seok Hong South Korea
Erez Podoly
Citations per year, relative to Erez Podoly Erez Podoly (= 1×) peers Hyun‐Seok Hong

Countries citing papers authored by Erez Podoly

Since Specialization
Citations

This map shows the geographic impact of Erez Podoly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erez Podoly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erez Podoly more than expected).

Fields of papers citing papers by Erez Podoly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erez Podoly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erez Podoly. The network helps show where Erez Podoly may publish in the future.

Co-authorship network of co-authors of Erez Podoly

This figure shows the co-authorship network connecting the top 25 collaborators of Erez Podoly. A scholar is included among the top collaborators of Erez Podoly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erez Podoly. Erez Podoly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Waiskopf, Nir, Keren Ofek, Adi Gilboa-Geffen, et al.. (2013). AChE and RACK1 Promote the Anti-Inflammatory Properties of Fluoxetine. Journal of Molecular Neuroscience. 53(3). 306–315. 27 indexed citations
2.
Podoly, Erez, Geula Hanin, & Hermona Soreq. (2010). Alanine-to-threonine substitutions and amyloid diseases: Butyrylcholinesterase as a case study. Chemico-Biological Interactions. 187(1-3). 64–71. 37 indexed citations
3.
Podoly, Erez, Deborah E. Shalev, Shani Shenhar‐Tsarfaty, et al.. (2009). The Butyrylcholinesterase K Variant Confers Structurally Derived Risks for Alzheimer Pathology♦. Journal of Biological Chemistry. 284(25). 17170–17179. 79 indexed citations
4.
Mor, Inbal, Ella H. Sklan, Erez Podoly, et al.. (2008). Acetylcholinesterase‐R increases germ cell apoptosis but enhances sperm motility. Journal of Cellular and Molecular Medicine. 12(2). 479–495. 31 indexed citations
5.
Podoly, Erez, Sophia Diamant, Naomi Melamed‐Book, et al.. (2008). Human Recombinant Butyrylcholinesterase Purified from the Milk of Transgenic Goats Interacts with Beta-Amyloid Fibrils and Suppresses Their Formation in vitro. Neurodegenerative Diseases. 5(3-4). 232–236. 35 indexed citations
6.
Meir, Amit, Erez Podoly, Henri R. Nordlund, et al.. (2008). Crystal Structure of Rhizavidin: Insights into the Enigmatic High-Affinity Interaction of an Innate Biotin-Binding Protein Dimer. Journal of Molecular Biology. 386(2). 379–390. 41 indexed citations
7.
Ofek, Keren, Erez Podoly, Haiheng Dong, et al.. (2007). Peripheral Site Acetylcholinesterase Blockade Induces RACK1-Associated Neuronal Remodeling. Neurodegenerative Diseases. 4(2-3). 171–184. 13 indexed citations
8.
Perry, Chava, Marjorie Pick, Erez Podoly, et al.. (2007). Acetylcholinesterase/C terminal binding protein interactions modify Ikaros functions, causing T lymphopenia. Leukemia. 21(7). 1472–1480. 24 indexed citations
9.
Sklan, Ella H., Erez Podoly, & Hermona Soreq. (2006). RACK1 has the nerve to act: Structure meets function in the nervous system. Progress in Neurobiology. 78(2). 117–134. 109 indexed citations
10.
Diamant, Sophia, Erez Podoly, Assaf Friedler, et al.. (2006). Butyrylcholinesterase attenuates amyloid fibril formation in vitro. Proceedings of the National Academy of Sciences. 103(23). 8628–8633. 150 indexed citations
11.
Meshorer, Eran, Debra Toiber, Jonathan Cohen, et al.. (2005). SC35 promotes sustainable stress-induced alternative splicing of neuronal acetylcholinesterase mRNA. Molecular Psychiatry. 10(11). 985–997. 73 indexed citations
12.
Podoly, Erez, Oded Livnah, Arik Eisenkraft, et al.. (2005). Inherited and acquired interactions between ACHE and PON1 polymorphisms modulate plasma acetylcholinesterase and paraoxonase activities. Journal of Neurochemistry. 92(5). 1216–1227. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026